Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease.
about
A systematic review and meta-analysis of plasma amyloid 1-42 and tau as biomarkers for Alzheimer's diseaseBlood-Based Proteomic Biomarkers of Alzheimer's Disease PathologyThe past and the future of Alzheimer's disease CSF biomarkers-a journey toward validated biochemical tests covering the whole spectrum of molecular eventsImago Mundi, Imago AD, Imago ADNIAmyloid β Protein and Alzheimer's Disease: When Computer Simulations Complement Experimental Studies.Association between cell-bound blood amyloid-β(1-40) levels and hippocampus volumeNovel plasma biomarker surrogating cerebral amyloid deposition.Bayesian graphical network analyses reveal complex biological interactions specific to Alzheimer's diseaseRecent Developments in Understanding Brain Aging: Implications for Alzheimer's Disease and Vascular Cognitive Impairment.Five-year biomarker progression variability for Alzheimer's disease dementia prediction: Can a complex instrumental activities of daily living marker fill in the gaps?Plasma β-amyloid in Alzheimer's disease and vascular disease.Production of inflammatory cytokines, cortisol, and Aβ1-40 in elderly oral cancer patients with postoperative deliriumWhole exome sequence-based association analyses of plasma amyloid-β in African and European Americans; the Atherosclerosis Risk in Communities-Neurocognitive Study.Biochemically-defined pools of amyloid-β in sporadic Alzheimer's disease: correlation with amyloid PET.Alzheimer's Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid.The Distinction of Amyloid-β Protein Precursor (AβPP) Ratio in Platelet Between Alzheimer's Disease Patients and Controls: A Systematic Review and Meta-Analysis.A Systematic Review of Longitudinal Studies Which Measure Alzheimer's Disease Biomarkers.Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals.Effect of apolipoprotein E phenotype on the association of plasma amyloid β and amyloid positron emission tomography imaging in Japan.Identification of key regions and residues controlling Aβ folding and assembly.Innate phagocytosis by peripheral blood monocytes is altered in Alzheimer's disease.A Translational Systems Pharmacology Model for Aβ Kinetics in Mouse, Monkey, and Human.Amyloid-β and tau complexity - towards improved biomarkers and targeted therapies.A randomized, exploratory molecular imaging study targeting amyloid β with a novel 8-OH quinoline in Alzheimer's disease: The PBT2-204 IMAGINE study.The clinical significance of plasma clusterin and Aβ in the longitudinal follow-up of patients with Alzheimer's disease.Plasma amyloid beta peptides: an Alzheimer's conundrum or a more accessible Alzheimer's biomarker?Association of Plasma Aβ40 Peptides, But Not Aβ42, with Coronary Artery Disease and Diabetes Mellitus.Plasma Amyloid Is Associated with White Matter and Subcortical Alterations and Is Modulated by Age and Seasonal Rhythms in Mouse Lemur Primates.Blood-Based Oligomeric and Other Protein Variant Biomarkers to Facilitate Pre-Symptomatic Diagnosis and Staging of Alzheimer's Disease.Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies.Aging and are determinative factors of plasma A42 levels
P2860
Q26771808-C1B9EF8A-BF26-4297-90B0-3721DFDAB0D4Q26774743-5EC23296-10A1-43E8-944A-12913C661367Q26781635-E92F8CB6-01BB-41D4-9179-50E0C2394FE8Q28650395-63D371F3-E7F4-4E7E-A873-E28D2DCEAA12Q33893017-E9487C69-0785-4E20-BE88-B027322A79CDQ34630564-A9A43433-7C51-44FB-9F74-1CD72000017FQ35074431-779A629F-63E1-4E4A-AA43-E159004B2890Q35843380-1819AFF5-7818-45D9-B047-9D68247E245DQ36853502-E7D610C1-8BC7-4A14-8336-7D2AB63EF366Q36933700-E51DFF6C-CC5A-4CD6-8208-0C1A34826A4DQ36949501-11036357-BF24-48B4-966F-6335543E8C46Q37385237-F6D1ABA1-3543-48D0-A77D-EEE9D08E1276Q38680904-1CDE434A-990C-4055-BF50-F7578CF15045Q38850382-5F7C4F09-7347-405D-98CC-1B0C4CE4B527Q39217840-9CEAEB51-E7FB-4810-9CBD-D6AF17A1BE0AQ39450376-30D017DD-F924-420D-9D8D-445CEC9E8C72Q40101067-69517882-DFCB-403D-A7C4-D9519BC26A22Q41690745-E1A7C0E5-877B-4F3B-8378-5D95D384744BQ42026115-357E1D23-AF40-4415-BF9D-64B13643928AQ42094428-3A929AFE-2FFC-4872-B6FF-2CC1BC9D3EAEQ42496183-9C3D0EEF-B40F-437C-9C31-7B6C112C989DQ42621620-158840A7-FD97-49DA-9FCB-83BF6CA1CF6CQ46240783-E7A29AD1-70D9-43A6-9D0F-7365310AC7E8Q47145223-282DD5FA-F343-45AC-8F00-9568CE9E9065Q47155881-E1A4F214-BCCD-4E63-A0F0-E987DF43533EQ48605183-269EF0F4-A2FA-4A29-96CE-A7F0C4E20358Q48818993-38B58DFB-DEBF-4EBC-9377-AF1780AF3629Q50354591-F259EA1C-0F7D-4D19-9BA9-0F68B165ACC4Q50753131-8B13BF1D-09DA-4808-8B8D-FDA5475B8B72Q51760876-3A36718D-74ED-4728-96E8-773CDBDE6D06Q57822409-472B9297-FA0E-43D1-9120-0FF6B523FA46
P2860
Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease.
@en
Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease.
@nl
type
label
Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease.
@en
Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease.
@nl
prefLabel
Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease.
@en
Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease.
@nl
P2093
P50
P1476
Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease.
@en
P2093
AIBL research group
Alan Rembach
Andrew D Watt
Brett O Trounson
Christopher C Rowe
Christopher J Fowler
David Ames
Hugo Vanderstichele
Joanne S Robertson
Kelly K Pertile
P356
10.1016/J.JALZ.2012.12.006
P50
P577
2013-03-13T00:00:00Z